<p>随着全球市场在消费者通胀上升和企业盈利强劲的复杂环境中航行，像标准普尔 500 指数和纳斯达克综合指数这样的指数已达到新高，主要受关键行业强劲表现的推动。在这种经济环境中，识别被低估的股票可以为寻求利用市场价格与内在价值之间差异的投资者提供潜在机会。</p>
<h3>基于现金流的十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估计）</strong></td>
<td><strong>折扣（估计）</strong></td>
</tr>
<tr>
<td>Surgical Science Sweden (OM:SUS)</td>
<td>SEK148.40</td>
<td>SEK294.49</td>
<td>49.6%</td>
</tr>
<tr>
<td>SpiderPlus (TSE:4192)</td>
<td>¥499.00</td>
<td>¥994.04</td>
<td>49.8%</td>
</tr>
<tr>
<td>RVRC Holding (OM:RVRC)</td>
<td>SEK45.68</td>
<td>SEK90.96</td>
<td>49.8%</td>
</tr>
<tr>
<td>Polaris Holdings (TSE:3010)</td>
<td>¥216.00</td>
<td>¥428.07</td>
<td>49.5%</td>
</tr>
<tr>
<td>Hugel (KOSDAQ:A145020)</td>
<td>₩351500.00</td>
<td>₩698441.84</td>
<td>49.7%</td>
</tr>
<tr>
<td>HDC Hyundai Development (KOSE:A294870)</td>
<td>₩23200.00</td>
<td>₩46090.66</td>
<td>49.7%</td>
</tr>
<tr>
<td>Grupo Hotelero Santa Fe. de (BMV:HOTEL *)</td>
<td>MX$3.60</td>
<td>MX$7.18</td>
<td>49.9%</td>
</tr>
<tr>
<td>Green Oleo (BIT:GRN)</td>
<td>€0.79</td>
<td>€1.57</td>
<td>49.8%</td>
</tr>
<tr>
<td>ATON Green Storage (BIT:ATON)</td>
<td>€2.13</td>
<td>€4.22</td>
<td>49.5%</td>
</tr>
<tr>
<td>Atea (OB:ATEA)</td>
<td>NOK143.00</td>
<td>NOK284.22</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们基于现金流的 469 只被低估全球股票的完整列表。</p>
<p>在这里，我们突出显示了我们筛选器中一些首选股票的子集。</p>
<h2>爱博医疗科技（北京）（SHSE:688050）</h2>
<p><strong>概述：</strong> 爱博医疗科技（北京）有限公司在医疗技术领域运营，专注于开发和制造眼科医疗设备，市值为 136.2 亿人民币。</p>
<p><strong>运营：</strong> 该公司主要通过其医疗产品部门产生收入，金额为 14.6 亿人民币。</p>
<p><strong>公允价值的估计折扣：</strong> 29.9%</p>
<p>爱博医疗科技（北京）的交易价格为 72.37 元，显著低于其估计的公允价值 103.21 元，基于现金流显示出潜在的低估。尽管最近每股股息减少至 0.35 元，但公司预计年收入增长 22.9%，年盈利增长 24.3%，均超过中国市场平均水平。分析师预计股价将大幅上涨 65.8%。</p>
<ul>
<li>我们的综合增长报告提出爱博医疗科技（北京）有望实现显著的财务增长。</li>
<li>通过阅读我们的健康报告，深入了解爱博医疗科技（北京）的资产负债表。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dc20de00-78ea-4048-94bf-72044b6428d6/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dc20de00-78ea-4048-94bf-72044b6428d6/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>SHSE:688050 截至 2025 年 7 月的折现现金流</p>
<h2>Nayax (TASE:NYAX)</h2>
<p><strong>概述：</strong> Nayax Ltd.是一家金融科技公司，为各地区的自动自助零售商和商家提供全面解决方案，市值为 57.8 亿新谢克尔。</p>
<p><strong>运营：</strong> 公司的收入主要来自其互联网软件和服务部门，产生了 3.3116 亿美元。</p>
<p><strong>公允价值的估计折扣：</strong> 18.5%</p>
<p>Nayax 的交易价格为 156.5 新谢克尔，低于其估计的公允价值 191.96 新谢克尔，显示出基于现金流的低估。该公司最近实现盈利，并预计年盈利增长 57.4%，超过以色列市场平均水平。预计收入将以每年 22.3% 的速度增长，得益于与 Lynkwell 在北美电动车充电解决方案方面的战略合作，并重申 2025 年显著收入增长的指导。</p>
<ul>
<li>我们编制的增长报告表明 Nayax 的未来前景可能向好。</li>
<li>通过我们的综合财务健康报告，深入了解 Nayax 的复杂情况。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9596c81c-53d8-4dbe-bd4f-a13422d8182c/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9596c81c-53d8-4dbe-bd4f-a13422d8182c/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TASE:NYAX 截至 2025 年 7 月的折现现金流</p>
<h2>Rorze (TSE:6323)</h2>
<p><strong>概述：</strong> Rorze Corporation 专注于全球半导体和液晶显示器生产的自动化系统的设计、开发、制造和销售，市值为 3395.4 亿日元。</p>
<p><strong>运营：</strong> 收入部门（以百万日元计）：半导体生产自动化系统 680 亿；液晶显示器生产自动化系统 125 亿。</p>
<p><strong>公允价值的估计折扣：</strong> 25.7%</p>
<p>Rorze 的交易价格为 1992 日元，低于其估计的公允价值 2681.68 日元，反映出基于现金流的低估。尽管最近利润率从 23.4% 下降至 15.7%，但预计年盈利将以 16% 的速度增长，超过日本市场 7.6% 的增长率。该公司最近完成了价值 19.8 亿日元的股票回购，可能在其股价在过去三个月的高波动中提升股东价值。</p>
<ul>
<li>我们最近的增长报告的见解表明 Rorze 的商业前景乐观。</li>
<li>点击这里通过我们的详细财务健康报告发现 Rorze 的细微差别。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>TSE:6323 截至 2025 年 7 月的折现现金流</p>
<h2>总结</h2>
<ul>
<li>深入了解我们基于现金流的 469 只被低估全球股票的完整目录。</li>
<li>这些股票中有哪几只在你的资产组合中？利用 Simply Wall St 的投资组合分析工具，全面了解它们的表现。</li>
<li>通过使用 Simply Wall St，加入聪明投资者的社区。它是免费的，并提供全球市场的专家级分析。</li>
</ul>
<h2>对其他选择感兴趣？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过提供可靠收入来源的稳健分红股票来多样化你的投资组合，以应对潜在的市场动荡。</li>
<li>通过分析师和管理层的乐观展望，推动你的投资组合中显示出强劲增长潜力的公司。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们仅基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

NYAX

爱博医疗

6323

<p>在消费者通胀上升和企业盈利强劲的背景下，几只全球股票被认为被低估。爱博医疗科技（SHSE:688050）目前交易价格为 72.37 元，低于其公允价值 103.21 元的 29.9%，预计收入增长为 22.9%。Nayax Ltd.（TASE:NYAX）显示出 18.5% 的折扣，交易价格为 156.5 新谢克尔，预计盈利增长为 57.4%。Rorze Corporation（TSE:6323）目前交易价格为 1992 日元，低于其公允价值的 25.7%，预计盈利增长为 16%。根据现金流分析，这些股票提供了潜在的投资机会</p>

<p>As global markets navigate a complex landscape marked by rising consumer inflation and robust corporate earnings, indices like the S&amp;P 500 and Nasdaq Composite have reached new highs, driven by strong performance in key sectors. Amidst this economic environment, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on discrepancies between market price and intrinsic value.</p>
<div class="lb-trans"><p>随着全球市场在消费者通胀上升和企业盈利强劲的复杂环境中航行，像标准普尔 500 指数和纳斯达克综合指数这样的指数已达到新高，主要受关键行业强劲表现的推动。在这种经济环境中，识别被低估的股票可以为寻求利用市场价格与内在价值之间差异的投资者提供潜在机会。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows</h3>
<div class="lb-trans"><h3>基于现金流的十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Surgical Science Sweden (OM:SUS)</td>
<td>SEK148.40</td>
<td>SEK294.49</td>
<td>49.6%</td>
</tr>
<tr>
<td>SpiderPlus (TSE:4192)</td>
<td>¥499.00</td>
<td>¥994.04</td>
<td>49.8%</td>
</tr>
<tr>
<td>RVRC Holding (OM:RVRC)</td>
<td>SEK45.68</td>
<td>SEK90.96</td>
<td>49.8%</td>
</tr>
<tr>
<td>Polaris Holdings (TSE:3010)</td>
<td>¥216.00</td>
<td>¥428.07</td>
<td>49.5%</td>
</tr>
<tr>
<td>Hugel (KOSDAQ:A145020)</td>
<td>₩351500.00</td>
<td>₩698441.84</td>
<td>49.7%</td>
</tr>
<tr>
<td>HDC Hyundai Development (KOSE:A294870)</td>
<td>₩23200.00</td>
<td>₩46090.66</td>
<td>49.7%</td>
</tr>
<tr>
<td>Grupo Hotelero Santa Fe. de (BMV:HOTEL *)</td>
<td>MX$3.60</td>
<td>MX$7.18</td>
<td>49.9%</td>
</tr>
<tr>
<td>Green Oleo (BIT:GRN)</td>
<td>€0.79</td>
<td>€1.57</td>
<td>49.8%</td>
</tr>
<tr>
<td>ATON Green Storage (BIT:ATON)</td>
<td>€2.13</td>
<td>€4.22</td>
<td>49.5%</td>
</tr>
<tr>
<td>Atea (OB:ATEA)</td>
<td>NOK143.00</td>
<td>NOK284.22</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估计）</strong></td>
<td><strong>折扣（估计）</strong></td>
</tr>
<tr>
<td>Surgical Science Sweden (OM:SUS)</td>
<td>SEK148.40</td>
<td>SEK294.49</td>
<td>49.6%</td>
</tr>
<tr>
<td>SpiderPlus (TSE:4192)</td>
<td>¥499.00</td>
<td>¥994.04</td>
<td>49.8%</td>
</tr>
<tr>
<td>RVRC Holding (OM:RVRC)</td>
<td>SEK45.68</td>
<td>SEK90.96</td>
<td>49.8%</td>
</tr>
<tr>
<td>Polaris Holdings (TSE:3010)</td>
<td>¥216.00</td>
<td>¥428.07</td>
<td>49.5%</td>
</tr>
<tr>
<td>Hugel (KOSDAQ:A145020)</td>
<td>₩351500.00</td>
<td>₩698441.84</td>
<td>49.7%</td>
</tr>
<tr>
<td>HDC Hyundai Development (KOSE:A294870)</td>
<td>₩23200.00</td>
<td>₩46090.66</td>
<td>49.7%</td>
</tr>
<tr>
<td>Grupo Hotelero Santa Fe. de (BMV:HOTEL *)</td>
<td>MX$3.60</td>
<td>MX$7.18</td>
<td>49.9%</td>
</tr>
<tr>
<td>Green Oleo (BIT:GRN)</td>
<td>€0.79</td>
<td>€1.57</td>
<td>49.8%</td>
</tr>
<tr>
<td>ATON Green Storage (BIT:ATON)</td>
<td>€2.13</td>
<td>€4.22</td>
<td>49.5%</td>
</tr>
<tr>
<td>Atea (OB:ATEA)</td>
<td>NOK143.00</td>
<td>NOK284.22</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 469 stocks from our Undervalued Global Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>点击这里查看我们基于现金流的 469 只被低估全球股票的完整列表。</p>
</div><p>Here we highlight a subset of our preferred stocks from the screener.</p>
<div class="lb-trans"><p>在这里，我们突出显示了我们筛选器中一些首选股票的子集。</p>
</div><h2>Eyebright Medical Technology (Beijing) (SHSE:688050)</h2>
<div class="lb-trans"><h2>爱博医疗科技（北京）（SHSE:688050）</h2>
</div><p><strong>Overview:</strong> Eyebright Medical Technology (Beijing) Co., Ltd. operates in the medical technology sector, focusing on developing and manufacturing ophthalmic medical devices, with a market cap of CN¥13.62 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 爱博医疗科技（北京）有限公司在医疗技术领域运营，专注于开发和制造眼科医疗设备，市值为 136.2 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its Medical Products segment, amounting to CN¥1.46 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其医疗产品部门产生收入，金额为 14.6 亿人民币。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 29.9%</p>
<div class="lb-trans"><p><strong>公允价值的估计折扣：</strong> 29.9%</p>
</div><p>Eyebright Medical Technology (Beijing) is trading at CN¥72.37, significantly below its estimated fair value of CN¥103.21, presenting a potential undervaluation based on cash flows. Despite a recent dividend decrease to CNY 0.35 per share, the company forecasts robust revenue growth of 22.9% annually and earnings growth of 24.3%, both outpacing the Chinese market averages. Analysts anticipate a substantial stock price increase of 65.8%.</p>
<div class="lb-trans"><p>爱博医疗科技（北京）的交易价格为 72.37 元，显著低于其估计的公允价值 103.21 元，基于现金流显示出潜在的低估。尽管最近每股股息减少至 0.35 元，但公司预计年收入增长 22.9%，年盈利增长 24.3%，均超过中国市场平均水平。分析师预计股价将大幅上涨 65.8%。</p>
</div><ul>
<li>Our comprehensive growth report raises the possibility that Eyebright Medical Technology (Beijing) is poised for substantial financial growth.</li>
<li>Get an in-depth perspective on Eyebright Medical Technology (Beijing)'s balance sheet by reading our health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的综合增长报告提出爱博医疗科技（北京）有望实现显著的财务增长。</li>
<li>通过阅读我们的健康报告，深入了解爱博医疗科技（北京）的资产负债表。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/dc20de00-78ea-4048-94bf-72044b6428d6/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/dc20de00-78ea-4048-94bf-72044b6428d6/chart/dcf?theme=light"/></p>
<p>SHSE:688050 Discounted Cash Flow as at Jul 2025</p>
<div class="lb-trans"><p>SHSE:688050 截至 2025 年 7 月的折现现金流</p>
</div><h2>Nayax (TASE:NYAX)</h2>
<div class="lb-trans"><h2>Nayax (TASE:NYAX)</h2>
</div><p><strong>Overview:</strong> Nayax Ltd. is a fintech company that provides comprehensive solutions for automated self-service retailers and merchants across various regions, with a market cap of ₪5.78 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Nayax Ltd.是一家金融科技公司，为各地区的自动自助零售商和商家提供全面解决方案，市值为 57.8 亿新谢克尔。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Internet Software and Services segment, which generated $331.16 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其互联网软件和服务部门，产生了 3.3116 亿美元。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 18.5%</p>
<div class="lb-trans"><p><strong>公允价值的估计折扣：</strong> 18.5%</p>
</div><p>Nayax is trading at ₪156.5, below its estimated fair value of ₪191.96, suggesting undervaluation based on cash flows. The company recently became profitable and forecasts strong earnings growth of 57.4% annually, outpacing the Israeli market average. Revenue is expected to grow by 22.3% per year, supported by strategic partnerships like the one with Lynkwell for EV charging solutions across North America and reaffirmed guidance for significant revenue increases in 2025.</p>
<div class="lb-trans"><p>Nayax 的交易价格为 156.5 新谢克尔，低于其估计的公允价值 191.96 新谢克尔，显示出基于现金流的低估。该公司最近实现盈利，并预计年盈利增长 57.4%，超过以色列市场平均水平。预计收入将以每年 22.3% 的速度增长，得益于与 Lynkwell 在北美电动车充电解决方案方面的战略合作，并重申 2025 年显著收入增长的指导。</p>
</div><ul>
<li>The growth report we've compiled suggests that Nayax's future prospects could be on the up.</li>
<li>Navigate through the intricacies of Nayax with our comprehensive financial health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们编制的增长报告表明 Nayax 的未来前景可能向好。</li>
<li>通过我们的综合财务健康报告，深入了解 Nayax 的复杂情况。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9596c81c-53d8-4dbe-bd4f-a13422d8182c/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/9596c81c-53d8-4dbe-bd4f-a13422d8182c/chart/dcf?theme=light"/></p>
<p>TASE:NYAX Discounted Cash Flow as at Jul 2025</p>
<div class="lb-trans"><p>TASE:NYAX 截至 2025 年 7 月的折现现金流</p>
</div><h2>Rorze (TSE:6323)</h2>
<div class="lb-trans"><h2>Rorze (TSE:6323)</h2>
</div><p><strong>Overview:</strong> Rorze Corporation specializes in designing, developing, manufacturing, and selling automation systems for semiconductor and flat panel display production globally, with a market cap of ¥339.54 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Rorze Corporation 专注于全球半导体和液晶显示器生产的自动化系统的设计、开发、制造和销售，市值为 3395.4 亿日元。</p>
</div><p><strong>Operations:</strong> Revenue Segments (in millions of ¥): Semiconductor production automation systems ¥68,000; Flat panel display production automation systems ¥12,500.</p>
<div class="lb-trans"><p><strong>运营：</strong> 收入部门（以百万日元计）：半导体生产自动化系统 680 亿；液晶显示器生产自动化系统 125 亿。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 25.7%</p>
<div class="lb-trans"><p><strong>公允价值的估计折扣：</strong> 25.7%</p>
</div><p>Rorze is trading at ¥1992, below its estimated fair value of ¥2681.68, reflecting undervaluation based on cash flows. Despite a recent decline in profit margins to 15.7% from 23.4%, earnings are forecast to grow at 16% annually, outpacing the Japanese market's growth rate of 7.6%. The company recently completed a share buyback worth ¥1.98 billion, potentially enhancing shareholder value amidst high volatility in its share price over the past three months.</p>
<div class="lb-trans"><p>Rorze 的交易价格为 1992 日元，低于其估计的公允价值 2681.68 日元，反映出基于现金流的低估。尽管最近利润率从 23.4% 下降至 15.7%，但预计年盈利将以 16% 的速度增长，超过日本市场 7.6% 的增长率。该公司最近完成了价值 19.8 亿日元的股票回购，可能在其股价在过去三个月的高波动中提升股东价值。</p>
</div><ul>
<li>Insights from our recent growth report point to a promising forecast for Rorze's business outlook.</li>
<li>Click here to discover the nuances of Rorze with our detailed financial health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们最近的增长报告的见解表明 Rorze 的商业前景乐观。</li>
<li>点击这里通过我们的详细财务健康报告发现 Rorze 的细微差别。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf?theme=light"/></p>
<p>TSE:6323 Discounted Cash Flow as at Jul 2025</p>
<div class="lb-trans"><p>TSE:6323 截至 2025 年 7 月的折现现金流</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>总结</h2>
</div><ul>
<li>Delve into our full catalog of 469 Undervalued Global Stocks Based On Cash Flows here.</li>
<li>Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.</li>
<li>Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入了解我们基于现金流的 469 只被低估全球股票的完整目录。</li>
<li>这些股票中有哪几只在你的资产组合中？利用 Simply Wall St 的投资组合分析工具，全面了解它们的表现。</li>
<li>通过使用 Simply Wall St，加入聪明投资者的社区。它是免费的，并提供全球市场的专家级分析。</li>
</ul>
</div><h2>Curious About Other Options?</h2>
<div class="lb-trans"><h2>对其他选择感兴趣？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过提供可靠收入来源的稳健分红股票来多样化你的投资组合，以应对潜在的市场动荡。</li>
<li>通过分析师和管理层的乐观展望，推动你的投资组合中显示出强劲增长潜力的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们仅基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。它不构成买卖任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

三只全球股票被估计低估了最多 29.9%